Skip to main content

DNB Asset Management AS

Position in NBIX — Neurocrine Biosciences Inc

CIK 1456670 Oslo, Q8

Position in NBIX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$20,281,597
+$1,675,694 QoQ
Shares Held
120,337
-14.8% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#109
of 768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DNB Asset Management AS holds $45,753,224 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (44.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
120,337 $20,281,597

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,281,597 120,337
2026-03-31 $18,605,903 141,232
2025-12-31 $19,779,186 139,457
2025-09-30 $17,422,281 124,108
2025-06-30 $14,446,808 114,940
2025-03-31 $14,169,187 128,112
2024-12-31 $16,137,985 118,227
2024-09-30 $13,218,844 114,727
2024-06-30 $10,317,815 74,946
2024-03-31 $8,819,708 63,948
2023-12-31 $8,675,473 65,843
2023-09-30 $9,003,600 80,032
2023-03-31 $9,728,962 96,117
2022-12-31 $10,350,789 86,661
2022-09-30 $9,321,626 87,766
2022-06-30 $12,314,161 126,325
2022-03-31 $12,670,687 135,154
2021-12-31 $11,976,860 140,623
2021-09-30 $11,344,138 118,279
2021-06-30 $13,451,862 138,223
2021-03-31 $11,550,285 118,769
2020-12-31 $3,374,590 35,207
2020-09-30 $1,190,076 12,376
2020-06-30 $1,509,872 12,376
2020-03-31 $943,308 10,899